Eva Compérat, MD, PhD, Hôpital Tenon, Sorbonne University, Paris, France, explores the genomic and tumor characterization of upper tract urothelial carcinoma, an uncommon urologic malignancy for which there has not been significant improvement in survival. This interview took place at the Global Congress on Prostate and Bladder Cancer (PROSCA/BLADDR 2022) in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
